Page last updated: 2024-08-24

dexmedetomidine and Affective Psychosis, Bipolar

dexmedetomidine has been researched along with Affective Psychosis, Bipolar in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's7 (77.78)2.80

Authors

AuthorsStudies
Citrome, L; De Vivo, M; Fava, M; Finman, J; Goldberg, JF; Kakar, R; Preskorn, SH; Risinger, R; Yocca, FD; Zeller, S1
Preskorn, SH1
Kakar, R; Preskorn, SH; Risinger, R1
Dantz, B; Henry, PH1
Abe, A; Ishiki, H; Takeda, Y1
Citrome, L; Rajachandran, L; Risinger, R; Robison, H1
Citrome, L; Ward, K1
Bulut, M; Ganidagli, S; Koruk, S; Mizrak, A; Oner, U1
Ackerman, AL; Mount, C1

Reviews

1 review(s) available for dexmedetomidine and Affective Psychosis, Bipolar

ArticleYear
The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy.
    Expert opinion on investigational drugs, 2020, Volume: 29, Issue:3

    Topics: Aggression; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Drug Development; Drugs, Investigational; Humans; Olanzapine; Psychomotor Agitation; Schizophrenia

2020

Trials

3 trial(s) available for dexmedetomidine and Affective Psychosis, Bipolar

ArticleYear
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial.
    JAMA, 2022, 02-22, Volume: 327, Issue:8

    Topics: Administration, Sublingual; Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Bipolar Disorder; Dexmedetomidine; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychomotor Agitation

2022
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
    Advances in therapy, 2022, Volume: 39, Issue:10

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Double-Blind Method; Humans; Schizophrenia; Treatment Outcome

2022
Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy.
    Journal of anesthesia, 2009, Volume: 23, Issue:1

    Topics: Adult; Anesthesia; Bipolar Disorder; Blood Pressure; Depressive Disorder, Major; Dexmedetomidine; Electroconvulsive Therapy; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Midazolam; Premedication; Propofol; Psychomotor Agitation; Respiratory Insufficiency; Seizures

2009

Other Studies

5 other study(ies) available for dexmedetomidine and Affective Psychosis, Bipolar

ArticleYear
How an Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications.
    Journal of psychiatric practice, 2022, 05-01, Volume: 28, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Anxiety; Bipolar Disorder; Dexmedetomidine; Humans; Locus Coeruleus

2022
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply.
    JAMA, 2022, 07-12, Volume: 328, Issue:2

    Topics: Administration, Sublingual; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Humans; Hypnotics and Sedatives; Psychomotor Agitation

2022
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
    JAMA, 2022, 07-12, Volume: 328, Issue:2

    Topics: Administration, Sublingual; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Humans; Hypnotics and Sedatives; Psychomotor Agitation

2022
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
    JAMA, 2022, 07-12, Volume: 328, Issue:2

    Topics: Administration, Sublingual; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Humans; Hypnotics and Sedatives; Psychomotor Agitation

2022
Successful treatment of acute mania and perineal abscess using dexmedetomidine sedation as adjunctive therapy.
    BMJ case reports, 2011, Oct-04, Volume: 2011

    Topics: Abscess; Adult; Anti-Bacterial Agents; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Diagnosis, Differential; Humans; Hypnotics and Sedatives; Male; Medication Adherence; Rectal Diseases; Ultrasonography

2011